Ascendant Diagnostics | Tear-Based Breast Cancer Diagnosis
Ascendant Dx is an early stage biotechnology company that was formed in September of 2010 with a focus on developing innovative new approaches to improve the diagnosis of serious disease and conditions.
Ascendant’s first product in development is an in vitro diagnostic assay to detect early stage breast cancer utilizing the proteomic profile present in tears. Implementation of our test in the market place will lead to greater rates of survivability by increasing early detection of breast cancer.
We believe our simple, non-invasive tear-based collection method will rapidly lead to increased participation by individuals who choose not to utilize currently available yearly screening methods.
- Life Sciences
- 535 W. Research Center Blvd.
- Fayetteville, AR 72701
- Omid Moghadam,
- Chief Executive Officer
- Anna Daily, PhD
- Senior Scientist
- Kimberley Fuller,
- Director of Market Research
- and Business Development
The entrepreneurial juggernaut Startup Weekend returns to central Arkansas this week. Startup Weekend Little Rock 2014 will start at 6:30 p.m. Friday at Acxiom's River Market District corporate headquarters and run through Sunday night.
AT&T on Wednesday announced a $35,000 donation to the EAST Initiative as part of its partnership with the Arkansas Regional Innovation Hub.
Little Rock tech founder Rod Ford will be the subject of the Arkansas Venture Center's Build IT series Tuesday beginning at 5:30 p.m. from the Little Rock Regional Chamber of Commerce.
Acorn wants to "intertwine" accountability and service when it comes to tracking service hours, help young people tell their stories and be "catalysts for change," and free up teachers from sometimes tedious paperwork.